Wordt geladen...
Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
The systemic immune‐inflammation index (SII = N × P/L) based on neutrophil (N), platelet (P) and lymphocyte (L) counts is used to predict the survival of patients with malignant tumours and can fully reflect the balance between host inflammatory and immune status. This study is conducted to explore...
Bewaard in:
| Gepubliceerd in: | J Cell Mol Med |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7077539/ https://ncbi.nlm.nih.gov/pubmed/31989747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14934 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|